Jason is Chief Financial Officer at Equillium. Jason is an accomplished executive with over 16 years of experience in corporate finance and strategy within the biotechnology industry. Prior to joining Equillium, he was Executive Vice President and Chief Financial Officer of Orexigen Therapeutics, Inc. where he was responsible for finance, accounting, and investor relations. During his tenure at Orexigen, Jason led the company’s financial planning and partnership finance functions, provided business development leadership, and served as a key financial advisor to executive management in setting business and financial strategy. Before Orexigen, Jason worked at Amylin Pharmaceuticals, Inc. for over five years, most recently as Senior Director of Finance, until the company was acquired by Bristol-Myers Squibb. Prior to joining Amylin, he held positions of increasing responsibility in finance and corporate strategy at Amgen, Inc. and at Baxter Healthcare Corporation. Jason is also a licensed professional engineer and has six years of experience in the environmental engineering industry.
Jason received his Bachelor of Science and Master of Science degrees in Civil Engineering from Stanford University and a Master of Business Administration from the Anderson School at the University of California, Los Angeles.